Adenovirus-Mediated Expression of Fas Ligand Induces Hepatic Apoptosis after Systemic Administration and Apoptosis ofEx Vivo-Infected Pancreatic Islet Allografts and Isografts
- 20 May 1997
- journal article
- research article
- Published by Mary Ann Liebert Inc in Human Gene Therapy
- Vol. 8 (8), 955-963
- https://doi.org/10.1089/hum.1997.8.8-955
Abstract
Fas ligand (FasL) mediates apoptosis of Fas-bearing cells and is expressed on a limited number of tissues, predominantly activated T lymphocytes. We describe the construction and biological activity of a replication-deficient type-5 adenovirus encoding murine FasL under the control of the cytomegalovirus (CMV) promoter (adCMV-FasL). In vitro, Jurkat cells undergo apoptosis when co-incubated with adCMV-FasL-infected COS cells. Systemic administration of adCMV-FasL to Wistar rats or DBA/2J mice results in widespread hepatic apoptosis and death in a dose-dependent manner within 72 hr, an effect not seen in lpr mice, or animals administered equivalent doses of adCMV-βgal. Murine pancreatic islets also undergo apoptosis when infected ex vivo with adCMV-FasL, resulting in uniform primary nonfunction when transplanted into syngeneic or allogeneic diabetic recipients. These results indicate that adCMV-FasL is a potentially useful tool to study Fas/FasL biology. Expression of Fas ligand (FasL) has recently been associated with immune privilege, and has been shown to prolong pancreatic islet allograft survival when expressed on co-transplanted syngeneic myoblasts. To explore the possibility of using Fas-mediated apoptosis as a tool to destroy activated T cells in an organ transplant setting, we have generated a replication-deficient type-5 adenovirus encoding murine FasL under the control of the cytomegalovirus (CMV) promoter (adCMV-FasL). In this paper, we demonstrate that adCMV-FasL is a potent inducer of apoptosis in vitro and in vivo. Furthermore, ex vivo infection of pancreatic islet isografts and allografts with adCMV-FasL resulted in widespread apoptosis of the islets and dramatically reduced survival in a murine pancreatic islet transplant model. These data suggest that adCMV-FasL may be a useful tool to further study Fas/FasL biology, but its ability to induce apoptosis of transduced grafts effectively is detrimental in the transplant setting.Keywords
This publication has 22 references indexed in Scilit:
- Prevention of Islet Allograft Rejection with Engineered Myoblasts Expressing FasL in MiceScience, 1996
- Fas Ligand-Induced Apoptosis as a Mechanism of Immune PrivilegeScience, 1995
- A role for CD95 ligand in preventing graft rejectionNature, 1995
- FAS-MEDIATED CYTOTOXICITY AN IMMUNOEFFECTOR OR IMMUNOREGULATORY PATHWAY IN T CELL-MEDIATED IMMUNE RESPONSES?Transplantation, 1995
- Local Fas/APO‐1 (CD95) ligand‐mediated tumor cell killing in vivoEuropean Journal of Immunology, 1995
- Apoptosis in the Pathogenesis and Treatment of DiseaseScience, 1995
- Autocrine T-cell suicide mediated by APO-1/(Fas/CD95)Nature, 1995
- Efficient Gene Transfer To Pancreatic Islets Mediated By Adenoviral VectorsTransplantation, 1995
- Protection from Fas-Mediated Apoptosis by a Soluble Form of the Fas MoleculeScience, 1994
- Characteristics of a Human Cell Line Transformed by DNA from Human Adenovirus Type 5Journal of General Virology, 1977